Zobrazeno 1 - 10 of 30 pro vyhledávání: '"Ilkcan Cokgor"'
2
[Untitled]
Autor: Allan H. Friedman, Henry S. Friedman, Ilkcan Cokgor
Publikováno v: Journal of Neuro-Oncology. 60:79-88
Neoplastic meningitis, which is the diffuse involvement of the leptomeninges by infiltrating cancer cells, may be caused by many systemic tumors. The treatment options for neoplastic meningitis disease remain unsatisfactory. In this review article, w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8f06b146c748ea32281809fb9c54ccaf
https://doi.org/10.1023/a:1020200317464
Zobrazit plný text záznamu
3
Phase I study of Gliadel™ wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas
Autor: Mary Lou Affronti, Maureen Early, Sandra Tourt-Uhlig, Jennifer A. Quinn, A. H. Friedman, Sara L. Zaknoen, James E. Herndon, Valerie Stafford-Fox, Roger E. McLendon, John H. Sampson, Henry S. Friedman, Sridharan Gururangan, Shari Edwards, James M. Provenzale, Jeremy N. Rich, Ilkcan Cokgor
Publikováno v: Neuro-Oncology. 3:246-250
Both Gliadel wafers [1,3-bis(2-chloroethyl)-1-nitrosourea] and temozolomide (TEMO) have been shown in independent studies to prolong survival of patients with recurrent malignant glioma following surgery and radiotherapy. On the basis of preclinical
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f2ab2202066d59cd4106a99db409caf
https://doi.org/10.1093/neuonc/3.4.246
Zobrazit plný text záznamu
4
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with131I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab?)2
Autor: James M. Provenzale, Lee M. Zehngebot, Gamal Akabani, Cynthia D. Guy, Michael R. Zalutsky, Allan H. Friedman, Carol J. Wikstrand, Henry S. Friedman, Ilkcan Cokgor, Darell D. Bigner
Publikováno v: Cancer. 91:1809-1813
Even with novel chemotherapeutic agents and external beam radiation therapy, the prognosis of neoplastic meningitis secondary to malignant melanoma is still dismal. The authors report a case study of a 46-year-old white female who presented with prog
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6505e28fba26c0ce36ce0da26053e677
https://doi.org/10.1002/1097-0142(20010501)91:9<1809::aid-cncr1200>3.0.co
Zobrazit plný text záznamu
7
Topotecan treatment of adults with primary malignant glioma
Autor: Henry S. Friedman, David Graden, Peter J. Houghton, Roger E. McLendon, Janice E. Zilisch, Allan H. Friedman, Ilkcan Cokgor, Susan G. Arbuck, Tracy Kerby, Scott Fields
Publikováno v: Cancer. 85:1160-1165
BACKGROUND Topotecan activity was evaluated for the treatment of malignant glioma. METHODS Sixty-three patients with newly diagnosed (n = 25) or recurrent (n = 38) malignant glioma were treated with topotecan at a dose of 2.6 mg/m2 over a 72-hour per
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f09e0aec98413f6dd5f8e24a0b8b3fbc
https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1160::aid-cncr21>3.0.co
Zobrazit plný text záznamu
8
[Untitled]
Autor: Darell D. Bigner, Carol J. Wikstrand, John H. Sampson, Ilkcan Cokgor
Publikováno v: Cancer and Metastasis Reviews. 18:451-464
The development of immunotherapeutic protocols for the treatment of human CNS neoplasia over the past two decades has been impressive. Several crucial aspects have been defined, characterized, and in many cases, optimized (Wikstrand CJ, Zalutsky MR,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cd2616bb650973ee07f276e57fc70f8c
https://doi.org/10.1023/a:1006354102377
Zobrazit plný text záznamu
9
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma
Autor: James M. Pluda, DM Kokkinakis, Robert C. Moschel, ME Dolan, Michael M. Haglund, Henry S. Friedman, Darell D. Bigner, Jeremy N. Rich, Tracy Kerby, Allan H. Friedman, David M. Ashley, Ilkcan Cokgor, James E. Herndon, S. C. Schold, Roger E. McLendon, Anthony E. Pegg
Publikováno v: Journal of Clinical Oncology. 16:3570-3575
PURPOSE The major mechanism of resistance to alkylnitrosourea therapy is the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT), which removes chlorethylation or methylation damage from the O6-position of guanine. O6-benzylguanine (O6-BG)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b69dc7850cb4b909803065f9a6f4c3e
https://doi.org/10.1200/jco.1998.16.11.3570
Zobrazit plný text záznamu
10
Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects
Autor: Susan Boulton, Allan H. Friedman, Gamal Akabani, Linda Cleveland, Roger E. McLendon, Carol J. Wikstrand, Ilkcan Cokgor, James E. Herndon, Henry S. Friedman, David A. Reardon, Darell D. Bigner, Michael R. Zalutsky
Publikováno v: Nuclear medicine and biology. 34(4)
The neurohistological findings in patients treated with targeted beta emitters such as (131)I are poorly described. We report a histopathologic analysis from patients treated with combined external beam therapy and a brachytherapy consisting of a (13
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b905d15d2c52714677a22e4eab10379
https://pubmed.ncbi.nlm.nih.gov/17499730
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje